Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation

Background: The G2019S-<i>LRRK2</i> gene mutation is a common cause of hereditary Parkinson’s disease (PD), associated with a higher frequency of the postural instability gait difficulty (PIGD) motor phenotype yet with preserved cognition. This study investigated neurophysiological chang...

Full description

Bibliographic Details
Main Authors: Eden Shkury, Shani Danziger-Schragenheim, Zoya Katzir, Yael Ezra, Nir Giladi, Anat Mirelman, Inbal Maidan
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/23/19/8266
_version_ 1797575195017347072
author Eden Shkury
Shani Danziger-Schragenheim
Zoya Katzir
Yael Ezra
Nir Giladi
Anat Mirelman
Inbal Maidan
author_facet Eden Shkury
Shani Danziger-Schragenheim
Zoya Katzir
Yael Ezra
Nir Giladi
Anat Mirelman
Inbal Maidan
author_sort Eden Shkury
collection DOAJ
description Background: The G2019S-<i>LRRK2</i> gene mutation is a common cause of hereditary Parkinson’s disease (PD), associated with a higher frequency of the postural instability gait difficulty (PIGD) motor phenotype yet with preserved cognition. This study investigated neurophysiological changes during motor and cognitive tasks in PD patients with and without the <i>G2019S-LRRK2</i> mutation. Methods: 33 iPD patients and 22 <i>LRRK2-PD</i> patients performed the visual Go/NoGo task (VGNG) during sitting (single-task) and walking (dual-task) while wearing a 64-channel EEG cap. Event-related potentials (ERP) from Fz and Pz, specifically N200 and P300, were extracted and analyzed to quantify brain activity patterns. Results: The <i>LRRK2-PD</i> group performed better in the VGNG than the iPD group (group*task; <i>p</i> = 0.05). During Go, the iPD group showed reduced N2 amplitude and prolonged N2 latency during walking, whereas the <i>LRRK2-PD</i> group showed only shorter latency (group*task <i>p</i> = 0.027). During NoGo, opposite patterns emerged; the iPD group showed reduced N2 and increased P3 amplitudes during walking while the <i>LRRK2-PD</i> group demonstrated increased N2 and reduced P3 (N2: group*task, <i>p</i> = 0.010, P3: group*task, <i>p</i> = 0.012). Conclusions: The <i>LRRK2-PD</i> group showed efficient early cognitive processes, reflected by N2, resulting in greater neural synchronization and prominent ERPs. These processes are possibly the underlying mechanisms for the observed better cognitive performance as compared to the iPD group. As such, future applications of intelligent medical sensing should be capable of capturing these electrophysiological patterns in order to enhance motor–cognitive functions.
first_indexed 2024-03-10T21:35:06Z
format Article
id doaj.art-e1378bb62dae4f5abf8f82d2331e42b7
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-10T21:35:06Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-e1378bb62dae4f5abf8f82d2331e42b72023-11-19T15:05:07ZengMDPI AGSensors1424-82202023-10-012319826610.3390/s23198266Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 MutationEden Shkury0Shani Danziger-Schragenheim1Zoya Katzir2Yael Ezra3Nir Giladi4Anat Mirelman5Inbal Maidan6Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelLaboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, IsraelBackground: The G2019S-<i>LRRK2</i> gene mutation is a common cause of hereditary Parkinson’s disease (PD), associated with a higher frequency of the postural instability gait difficulty (PIGD) motor phenotype yet with preserved cognition. This study investigated neurophysiological changes during motor and cognitive tasks in PD patients with and without the <i>G2019S-LRRK2</i> mutation. Methods: 33 iPD patients and 22 <i>LRRK2-PD</i> patients performed the visual Go/NoGo task (VGNG) during sitting (single-task) and walking (dual-task) while wearing a 64-channel EEG cap. Event-related potentials (ERP) from Fz and Pz, specifically N200 and P300, were extracted and analyzed to quantify brain activity patterns. Results: The <i>LRRK2-PD</i> group performed better in the VGNG than the iPD group (group*task; <i>p</i> = 0.05). During Go, the iPD group showed reduced N2 amplitude and prolonged N2 latency during walking, whereas the <i>LRRK2-PD</i> group showed only shorter latency (group*task <i>p</i> = 0.027). During NoGo, opposite patterns emerged; the iPD group showed reduced N2 and increased P3 amplitudes during walking while the <i>LRRK2-PD</i> group demonstrated increased N2 and reduced P3 (N2: group*task, <i>p</i> = 0.010, P3: group*task, <i>p</i> = 0.012). Conclusions: The <i>LRRK2-PD</i> group showed efficient early cognitive processes, reflected by N2, resulting in greater neural synchronization and prominent ERPs. These processes are possibly the underlying mechanisms for the observed better cognitive performance as compared to the iPD group. As such, future applications of intelligent medical sensing should be capable of capturing these electrophysiological patterns in order to enhance motor–cognitive functions.https://www.mdpi.com/1424-8220/23/19/8266Parkinson’s diseasecognitionLRRK2electroencephalography (EEG)event-related potential (ERP)
spellingShingle Eden Shkury
Shani Danziger-Schragenheim
Zoya Katzir
Yael Ezra
Nir Giladi
Anat Mirelman
Inbal Maidan
Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
Sensors
Parkinson’s disease
cognition
LRRK2
electroencephalography (EEG)
event-related potential (ERP)
title Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
title_full Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
title_fullStr Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
title_full_unstemmed Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
title_short Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
title_sort differences in eeg event related potentials during dual task in parkinson s disease carriers and non carriers of the g2019s lrrk2 mutation
topic Parkinson’s disease
cognition
LRRK2
electroencephalography (EEG)
event-related potential (ERP)
url https://www.mdpi.com/1424-8220/23/19/8266
work_keys_str_mv AT edenshkury differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT shanidanzigerschragenheim differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT zoyakatzir differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT yaelezra differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT nirgiladi differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT anatmirelman differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation
AT inbalmaidan differencesineegeventrelatedpotentialsduringdualtaskinparkinsonsdiseasecarriersandnoncarriersoftheg2019slrrk2mutation